Structural genomics-Impact on biomedicine and drug discovery

Experimental Cell Research

Volumn 316, Issue 8, 2010, Pages 1332-1338

  Weigelt, Johan ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Chemical biology; Drug discovery; High throughput structural biology; Structural genomics

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; GERANYLTRANSFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; RISEDRONIC ACID; ZOLEDRONIC ACID; PROTEIN;

AMINO ACID SEQUENCE; BIOMEDICINE; CRYSTALLIZATION; DRUG MECHANISM; DRUG TARGETING; HUMAN; MOLECULAR INTERACTION; MOLECULAR MECHANICS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; OSTEOCLAST; OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PURIFICATION; REVIEW; STRUCTURAL GENOMICS; X RAY CRYSTALLOGRAPHY; X RAY DIFFRACTION; ANIMAL; BIOLOGY; CHEMISTRY; DRUG DESIGN; DRUG DEVELOPMENT; GENETICS; GENOMICS; METABOLISM;

ANIMALS; COMPUTATIONAL BIOLOGY; DRUG DESIGN; DRUG DISCOVERY; GENOMICS; HUMANS; PROTEINS;

EID: 77952555814     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2010.02.041     Document Type: Review

References (45)

1. Yokoyama S., Hirota H., Kigawa T., Yabuki T., Shirouzu M., Terada T., Ito Y., Matsuo Y., Kuroda Y., Nishimura Y., Kyogoku Y., Miki K., Masui R., Kuramitsu S. Structural genomics projects in Japan. Nat. Struct. Biol. 2000, 7 Suppl:943-945.
2. Heinemann U., Frevert J., Hofmann K., Illing G., Maurer C., Oschkinat H., Saenger W. An integrated approach to structural genomics. Prog. Biophys. Mol. Biol. 2000, 73:347-362.
3. Christendat D., Yee A., Dharamsi A., Kluger Y., Savchenko A., Cort J.R., Booth V., Mackereth C.D., Saridakis V., Ekiel I., Kozlov G., Maxwell K.L., Wu N., McIntosh L.P., Gehring K., Kennedy M.A., Davidson A.R., Pai E.F., Gerstein M., Edwards A.M., Arrowsmith C.H. Structural proteomics of an archaeon. Nat. Struct. Biol. 2000, 7:903-909.
4. Zarembinski T.I., Hung L.W., Mueller-Dieckmann H.J., Kim K.K., Yokota H., Kim R., Kim S.H. Structure-based assignment of the biochemical function of a hypothetical protein: a test case of structural genomics. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:15189-15193.
5. Dry S., McCarthy S., Harris T. Structural genomics in the biotechnology sector. Nat. Struct. Biol. 2000, 7 Suppl:946-949.
6. Stuart D.I., Jones E.Y., Wilson K.S., Daenke S. SPINE: Structural Proteomics IN Europe-the best of both worlds. Acta Crystallogr. Section D 2006, 62. ii-i, doi:10.1107/S0907444906035347.
7. Cottingham K. The Structural Genomics Consortium makes its presence known. J. Proteome Res. 2008, 7:5073.
8. Joachimiak A. High-throughput crystallography for structural genomics. Curr. Opin. Struct. Biol. 2009, 19:573-584.
9. Van Voorhis W.C., Hol W.G., Myler P.J., Stewart L.J. The role of medical structural genomics in discovering new drugs for infectious diseases. PLoS Comput. Biol. 2009, 5:e1000530.
10. Myler P.J., Stacy R., Stewart L., Staker B.L., Van Voorhis W.C., Varani G., Buchko G.W. The Seattle Structural Genomics Center for Infectious Disease (SSGCID). Infect. Disord. Drug Targets 2009, 9:493-506.
11. Graslund S., Nordlund P., Weigelt J., Hallberg B.M., Bray J., Gileadi O., Knapp S., Oppermann U., Arrowsmith C., Hui R., Ming J., dhe-Paganon S., Park H.W., Savchenko A., Yee A., Edwards A., Vincentelli R., Cambillau C., Kim R., Kim S.H., Rao Z., Shi Y., Terwilliger T.C., Kim C.Y., Hung L.W., Waldo G.S., Peleg Y., Albeck S., Unger T., Dym O., Prilusky J., Sussman J.L., Stevens R.C., Lesley S.A., Wilson I.A., Joachimiak A., Collart F., Dementieva I., Donnelly M.I., Eschenfeldt W.H., Kim Y., Stols L., Wu R., Zhou M., Burley S.K., Emtage J.S., Sauder J.M., Thompson D., Bain K., Luz J., Gheyi T., Zhang F., Atwell S., Almo S.C., Bonanno J.B., Fiser A., Swaminathan S., Studier F.W., Chance M.R., Sali A., Acton T.B., Xiao R., Zhao L., Ma L.C., Hunt J.F., Tong L., Cunningham K., Inouye M., Anderson S., Janjua H., Shastry R., Ho C.K., Wang D., Wang H., Jiang M., Montelione G.T., Stuart D.I., Owens R.J., Daenke S., Schutz A., Heinemann U., Yokoyama S., Bussow K., Gunsalus K.C. Protein production and purification. Nat. Methods 2008, 5:135-146.
12. Page R., Stevens R.C. Crystallization data mining in structural genomics: using positive and negative results to optimize protein crystallization screens. Methods 2004, 34:373-389.
13. O'Reilly M., Vinkovic M., Sharff A., Jhoti H. High throughput protein crystallography: developments in crystallisation, data collection and data processing. Drug Discov. Today 2006, 3:451-456.
14. Snell G., Cork C., Nordmeyer R., Cornell E., Meigs G., Yegian D., Jaklevic J., Jin J., Stevens R.C., Earnest T. Automated sample mounting and alignment system for biological crystallography at a synchrotron source. Structure 2004, 12:537-545.
15. Yamada Y., Phonda N., Matsugaki N., Igarashi N., Hiraki M., Wakatsuki S. Implementation of remote monitoring and diffraction evaluation systems at the Photon Factory macromolecular crystallography beamlines. J. Synchrotron Radiat. 2008, 15:296-299.
16. Beteva A., Cipriani F., Cusack S., Delageniere S., Gabadinho J., Gordon E.J., Guijarro M., Hall D.R., Larsen S., Launer L., Lavault C.B., Leonard G.A., Mairs T., McCarthy A., McCarthy J., Meyer J., Mitchell E., Monaco S., Nurizzo D., Pernot P., Pieritz R., Ravelli R.G., Rey V., Shepard W., Spruce D., Stuart D.I., Svensson O., Theveneau P., Thibault X., Turkenburg J., Walsh M., McSweeney S.M. High-throughput sample handling and data collection at synchrotrons: embedding the ESRF into the high-throughput gene-to-structure pipeline. Acta Crystallogr. D Biol. Crystallogr. 2006, 62:1162-1169.
17. Pohl E., Ristau U., Gehrmann T., Jahn D., Robrahn B., Malthan D., Dobler H., Hermes C. Automation of the EMBL Hamburg protein crystallography beamline BW7B. J. Synchrotron Radiat. 2004, 11:372-377.
18. McPhillips T.M., McPhillips S.E., Chiu H.J., Cohen A.E., Deacon A.M., Ellis P.J., Garman E., Gonzalez A., Sauter N.K., Phizackerley R.P., Soltis S.M., Kuhn P. Blu-Ice and the Distributed Control System: software for data acquisition and instrument control at macromolecular crystallography beamlines. J. Synchrotron Radiat. 2002, 9:401-406.
19. Minor W., Cymborowski M., Otwinowski Z., Chruszcz M. HKL-3000: the integration of data reduction and structure solution-from diffraction images to an initial model in minutes. Acta Crystallogr. D Biol. Crystallogr. 2006, 62:859-866.
20. Liu G., Shen Y., Atreya H.S., Parish D., Shao Y., Sukumaran D.K., Xiao R., Yee A., Lemak A., Bhattacharya A., Acton T.A., Arrowsmith C.H., Montelione G.T., Szyperski T. NMR data collection and analysis protocol for high-throughput protein structure determination. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:10487-10492.
21. Zwart P.H., Afonine P.V., Grosse-Kunstleve R.W., Hung L.W., Ioerger T.R., McCoy A.J., McKee E., Moriarty N.W., Read R.J., Sacchettini J.C., Sauter N.K., Storoni L.C., Terwilliger T.C., Adams P.D. Automated structure solution with the PHENIX suite. Methods Mol. Biol. 2008, 426:419-435.
22. Levin E.J., Quick M., Zhou M. Crystal structure of a bacterial homologue of the kidney urea transporter. Nature 2009, 462:757-761.
23. Congreve M., Murray C.W., Blundell T.L. Structural biology and drug discovery. Drug Discov. Today 2005, 10:895-907.
24. Nair R., Liu J., Soong T.T., Acton T.B., Everett J.K., Kouranov A., Fiser A., Godzik A., Jaroszewski L., Orengo C., Montelione G.T., Rost B. Structural genomics is the largest contributor of novel structural leverage. J. Struct. Funct. Genomics 2009, 10:181-191.
25. Dessailly B.H., Nair R., Jaroszewski L., Fajardo J.E., Kouranov A., Lee D., Fiser A., Godzik A., Rost B., Orengo C. PSI-2: structural genomics to cover protein domain family space. Structure 2009, 17:869-881.
26. Coutard B., Gorbalenya A.E., Snijder E.J., Leontovich A.M., Poupon A., De Lamballerie X., Charrel R., Gould E.A., Gunther S., Norder H., Klempa B., Bourhy H., Rohayem J., L'Hermite E., Nordlund P., Stuart D.I., Owens R.J., Grimes J.M., Tucker P.A., Bolognesi M., Mattevi A., Coll M., Jones T.A., Aqvist J., Unge T., Hilgenfeld R., Bricogne G., Neyts J., La Colla P., Puerstinger G., Gonzalez J.P., Leroy E., Cambillau C., Romette J.L., Canard B. The VIZIER project: preparedness against pathogenic RNA viruses. Antiviral Res. 2008, 78:37-46.
27. Mehlin C. Structure-based drug discovery for Plasmodium falciparum. Comb. Chem. High Throughput Screen 2005, 8:5-14.
28. Vedadi M., Lew J., Artz J., Amani M., Zhao Y., Dong A., Wasney G.A., Gao M., Hills T., Brokx S., Qiu W., Sharma S., Diassiti A., Alam Z., Melone M., Mulichak A., Wernimont A., Bray J., Loppnau P., Plotnikova O., Newberry K., Sundararajan E., Houston S., Walker J., Tempel W., Bochkarev A., Kozieradzki I., Edwards A., Arrowsmith C., Roos D., Kain K., Hui R. Genome-scale protein expression and structural biology of Plasmodium falciparum and related Apicomplexan organisms. Mol. Biochem. Parasitol. 2007, 151:100-110.
29. Goulding C.W., Apostol M., Anderson D.H., Gill H.S., Smith C.V., Kuo M.R., Yang J.K., Waldo G.S., Suh S.W., Chauhan R., Kale A., Bachhawat N., Mande S.C., Johnston J.M., Lott J.S., Baker E.N., Arcus V.L., Leys D., McLean K.J., Munro A.W., Berendzen J., Sharma V., Park M.S., Eisenberg D., Sacchettini J., Alber T., Rupp B., Jacobs W., Terwilliger T.C. The TB Structural Genomics Consortium: providing a structural foundation for drug discovery. Curr. Drug Targets Infect. Disord. 2002, 2:121-141.
30. Baker E.N. Structural genomics as an approach towards understanding the biology of tuberculosis. J. Struct. Funct. Genomics 2007, 8:57-65.
31. Edwards A. Large-scale structural biology of the human proteome. Annu. Rev. Biochem. 2009, 78:541-568.
32. Kavanagh K.L., Guo K., Dunford J.E., Wu X., Knapp S., Ebetino F.H., Rogers M.J., Russell R.G., Oppermann U. The molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugs. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:7829-7834.
33. Dunford J.E., Kwaasi A.A., Rogers M.J., Barnett B.L., Ebetino F.H., Russell R.G., Oppermann U., Kavanagh K.L. Structure-activity relationships among the nitrogen containing bisphosphonates in clinical use and other analogues: time-dependent inhibition of human farnesyl pyrophosphate synthase. J. Med. Chem. 2008, 51:2187-2195.
34. Rodon J., Iniesta M.D., Papadopoulos K. Development of PARP inhibitors in oncology. Expert Opin. Investig. Drugs 2009, 18:31-43.
35. Kinoshita T., Nakanishi I., Warizaya M., Iwashita A., Kido Y., Hattori K., Fujii T. Inhibitor-induced structural change of the active site of human poly(ADP-ribose) polymerase. FEBS Lett. 2004, 556:43-46.
36. Smith S., Giriat I., Schmitt A., de Lange T. Tankyrase, a poly(ADP-ribose) polymerase at human telomeres. Science 1998, 282:1484-1487.
37. Huang S.M., Mishina Y.M., Liu S., Cheung A., Stegmeier F., Michaud G.A., Charlat O., Wiellette E., Zhang Y., Wiessner S., Hild M., Shi X., Wilson C.J., Mickanin C., Myer V., Fazal A., Tomlinson R., Serluca F., Shao W., Cheng H., Shultz M., Rau C., Schirle M., Schlegl J., Ghidelli S., Fawell S., Lu C., Curtis D., Kirschner M.W., Lengauer C., Finan P.M., Tallarico J.A., Bouwmeester T., Porter J.A., Bauer A., Cong F. Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling. Nature 2009, 461:614-620.
38. McCabe N., Cerone M.A., Ohishi T., Seimiya H., Lord C.J., Ashworth A. Targeting tankyrase 1 as a therapeutic strategy for BRCA-associated cancer. Oncogene 2009, 28:1465-1470.
39. Fedorov O., Marsden B., Pogacic V., Rellos P., Muller S., Bullock A.N., Schwaller J., Sundstrom M., Knapp S. A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:20523-20528.
40. Weigelt J. The case for open-access chemical biology. A strategy for pre-competitive medicinal chemistry to promote drug discovery. EMBO Rep. 2009, 10:941-945.
41. Uhlen M., Graslund S., Sundstrom M. A pilot project to generate affinity reagents to human proteins. Nat. Methods 2008, 5:854-855.
42. Michnick S.W., Sidhu S.S. Submitting antibodies to binding arbitration. Nat. Chem. Biol. 2008, 4:326-329.
43. Gerlt J.A. A Protein Structure (or function?) Initiative. Structure 2007, 15:1353-1356.
44. Kuznetsova E., Proudfoot M., Sanders S.A., Reinking J., Savchenko A., Arrowsmith C.H., Edwards A.M., Yakunin A.F. Enzyme genomics: application of general enzymatic screens to discover new enzymes. FEMS Microbiol. Rev. 2005, 29:263-279.
45. Mosca R., Pons C., Fernandez-Recio J., Aloy P. Pushing structural information into the yeast interactome by high-throughput protein docking experiments. PLoS Comput. Biol. 2009, 5:e1000490.